An A[gamma]-globin G-A gene polymorphism associated with [beta]039 thalassemia globin gene and high fetal hemoglobin production

Increase of the expression of [gamma]-globin gene and high production of fetal hemoglobin (HbF) in [beta]-thalassemia patients is widely accepted as associated with a milder or even asymptomatic disease. The search for HbF-associated polymorphisms (such as the XmnI, BCL11A and MYB polymorphisms) has...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:BMC medical genetics 2017-08, Vol.18 (1)
Hauptverfasser: Breveglieri, Giulia, Bianchi, Nicoletta, Cosenza, Lucia Carmela, Gamberini, Maria Rita, Chiavilli, Francesco, Zuccato, Cristina, Montagner, Giulia, Borgatti, Monica, Lampronti, Ilaria, Finotti, Alessia, Gambari, Roberto
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Increase of the expression of [gamma]-globin gene and high production of fetal hemoglobin (HbF) in [beta]-thalassemia patients is widely accepted as associated with a milder or even asymptomatic disease. The search for HbF-associated polymorphisms (such as the XmnI, BCL11A and MYB polymorphisms) has recently gained great attention, in order to stratify [beta]-thalassemia patients with respect to expectancy of the first transfusion, need for annual intake of blood, response to HbF inducers (the most studied of which is hydroxyurea). A[gamma]-globin gene sequencing was performed on genomic DNA isolated from a total of 75 [beta]-thalassemia patients, including 31 [beta].sup.039/[beta].sup.039, 33 [beta].sup.039/[beta].sup.+IVSI-110, 9 [beta].sup.+IVSI-110/[beta].sup.+IVSI-110, one [beta].sup.0IVSI-1/[beta].sup.+IVSI-6 and one [beta].sup.039/[beta].sup.+IVSI-6. The results show that the rs368698783 polymorphism is present in [beta]-thalassemia patients in the 5'UTR sequence (+25) of the A[gamma]-globin gene, known to affect the LYAR (human homologue of mouse Ly-1 antibody reactive clone) binding site 5'-GGTTAT-3'. This A[gamma](+25 G->A) polymorphism is associated with the G[gamma]-globin-XmnI polymorphism and both are linked with the [beta].sup.039-globin gene, but not with the [beta].sup.+IVSI-110-globin gene. In agreement with the expectation that this mutation alters the LYAR binding activity, we found that the A[gamma](+25 G->A) and G[gamma]-globin-XmnI polymorphisms are associated with high HbF in erythroid precursor cells isolated from [beta].sup.039/[beta].sup.039 thalassemia patients. As a potential explanation of our findings, we hypothesize that in [beta]-thalassemia the G[gamma]-globin-XmnI/A[gamma]-globin-(G->A) genotype is frequently under genetic linkage with [beta].sup.0-thalassemia mutations, but not with the [beta].sup.+-thalassemia mutation here studied (i.e. [beta].sup.+IVSI-110) and that this genetic combination has been selected within the population of [beta].sup.0-thalassemia patients, due to functional association with high HbF. Here we describe the characterization of the rs368698783 (+25 G->A) polymorphism of the A[gamma]-globin gene associated in [beta].sup.039 thalassemia patients with high HbF in erythroid precursor cells.
ISSN:1471-2350
1471-2350
DOI:10.1186/s12881-017-0450-3